Medical wearables and remote patient monitoring are transforming healthcare delivery – enabling continuous health monitoring outside clinical settings and creating data streams that support earlier intervention and chronic disease management. Cardiac monitoring wearables, continuous glucose monitors, remote vital signs monitors, and hospital-at-home technology companies are all evaluating new market entry opportunities as healthcare systems seek to reduce hospital bed dependency and improve chronic disease management. GreyRadius helps MedTech wearable businesses validate clinical demand, navigate regulatory requirements, execute GTM plans, and raise capital.
Why now? Chronic disease burden is growing rapidly across Southeast Asia, South Asia, and the Gulf – diabetes, cardiovascular disease, and respiratory conditions are all increasing in prevalence and driving demand for remote monitoring solutions that reduce hospital visits and improve disease management. National digital health strategies are creating funded procurement pathways for remote monitoring technology.
Medical wearable market is projected to reach $95B by 2030 – growing at 22% annually as continuous glucose monitoring, cardiac monitoring, and hospital-at-home technology achieve mainstream clinical adoption.
Continuous glucose monitoring is the fastest-growing medical wearable segment – the growing diabetes epidemic across Southeast Asia, South Asia, and the Gulf is creating significant demand for affordable CGM devices.
Hospital-at-home programmes are being implemented by government health systems – patients recovering from surgery or managing chronic conditions can be monitored remotely, reducing hospital bed usage and patient cost.
AI-powered clinical decision support integrated with wearable data is creating new value propositions – wearables that not only collect data but generate clinical alerts and recommendations are achieving faster hospital system adoption.
If you recognise your situation below, we can help.
Clinical demand and hospital system validation
You need to validate that clinicians and hospital systems in your target market are willing to integrate remote monitoring into clinical workflows.
Regulatory SaMD pathway
You need to understand medical device classification, clinical evidence requirements, and registration processes for health wearables in your target market.
Hospital and payer partnership identification
You need to identify hospital groups, insurance companies, and government health programmes as commercial partners and reimbursement channels.
GTM for a medical wearable or remote monitoring product
You have a health wearable and need a go-to-market strategy covering hospital, physician, and corporate wellness channels.
Raising capital for a MedTech wearables venture
You are raising investment and need a pitch book grounded in clinical validation data and market sizing.
Competitive intelligence
You need to understand how competing medical wearable companies are positioned and winning hospital contracts in your target market.
Every engagement is grounded in primary research and delivers a measurable outcome.
Validate clinical demand for medical wearables in a new market. Covers physician and hospital administrator interviews, regulatory pathway mapping, competitive analysis, and a Go/Defer/Kill recommendation.
Learn more →Full financial and operational feasibility for medical wearable launches. Covers clinical demand modelling, regulatory pathway cost, revenue model, and investor-ready projections.
Learn more →End-to-end market entry for MedTech wearable companies. Regulatory pathway, hospital partner identification, physician ICP, and first-hospital or first-clinical-programme acquisition.
Learn more →Embedded GTM team for medical wearable companies. Hospital outreach, physician champion development, and first-revenue milestone tracking.
Learn more →Investor-ready pitch books for MedTech wearable ventures. Clinical-demand-validated market sizing, regulatory timeline, and investor identification.
Learn more →AI use-case prioritisation in medical wearables – from clinical alert generation and anomaly detection to personalised health intervention recommendations and predictive deterioration modelling.
Learn more →80% of our insight comes from first-party interviews with buyers, competitors, and regulators – not secondary data that everyone else has.
Our AI layer compresses research timelines by 60% and surfaces pattern-matching from 200+ prior mandates – so you get faster, deeper answers.
We measure success by first contracts signed, capital raised, and markets entered – not deliverables produced. Every mandate has a milestone.
200+
Projects delivered
100+
SaaS & tech clients
80%
Primary research-led
4
Countries / offices
Medical Devices · Market Entry
Medical Devices · GTM
Medical Devices · Assessment
Both. We work with regulated medical wearables on regulatory pathway and market entry, and with consumer health wearables seeking clinical partnerships on GTM and market entry.
Southeast Asia, South Asia, and the Gulf – markets with significant chronic disease burden and growing digital health infrastructure investment.
Typically 8–12 weeks given the complexity of regulatory pathway mapping and clinical stakeholder research.
Yes. Hospital and payer identification and initial commercial conversations are part of our market entry execution service.
GreyRadius research notes, market entry signals, and sector briefs – delivered weekly. No fluff.
Not sure which engagement fits? Take our free 2-minute diagnostic →
Primary research. AI-enabled analysis, expert-reviewed. Outcomes-based delivery – across Southeast Asia, South Asia, Gulf.
